β-Nicotinamide Mononucleotide
Abstract
Clinical Trials
GSB-02 on Aging Biomarkers and Functional Outcomes
+23.6%
+21.1%
+30.9%
+31.8%
Primary Endpoint Results at 12 Months
Title
Secondary Endpoint Results at 12 Months
Title
Benefit Study
Title
Quality Control Testing Battery
Title
Title
Title
Interactions
Formulated for transformative long-term health
Our Scientific and Clinical Advisory Board
Formulated for transformative long-term health.
Our Scientific and Clinical Advisory Board
Questions?
We're here to help.
